top of page
Teleretinal Screening using AI
Revolutionizing Teleretinal Screening Services with fully autonomous AI
Deliver on-the-spot results using AI instead of human readers
AEYE Health’s FDA-cleared AI detects referable diabetic retinopathy autonomously and provides a result within seconds, enabling teleretinal screening services to save costs and deliver on-the-spot results.
_edited_edited.png)
Instant diagnosis, on-the-spot results
Image analysis is performed fully autonomously by the AI; results delivered instantly
Time and cost
efficiency
AI analyzes exams in less than
5-seconds and scales on demand to process as many exams as needed
One image per eye;
real-time quality checks
Image analyzed for quality in real-time and feedback provided to operator to allow a retake when needed
Accurate diagnosis,
every time
93% sensitivity and 91.4% specificity for diagnosing more-than-mild diabetic retinopathy (K221183)
Seamless Integration
API integration to send exams and receive results; scalable to process as many exams as needed
_edited.png)
Get Started Today!
Ready to transform your teleretinal screening services?
Contact us today to schedule a demo and see firsthand how AEYE-DS can elevate your service.
Set Up a CallÂ
bottom of page